Business Advisory services                  Life Sciences Consulting                  Product Development                  ANDAs                  FTFs                  505 b 2 a                  Late Stage Assets                  Phase-II Trials                  Marketing Authorizationís                  Dossiers                  Site Transfers                  Scale ups                   Tail End Brands                  Technologies and Know-how                  Project Management                   Business Excellence & Six Sigma
Our client, a leading Asian pharmaceutical company, aimed to enhance its development efficiency and decision making, as a part of an internal cross-functional design initiative cutting across R&D and Project Management functions. The overall initiative was a step in order to achieve the next phase of goals on the road to 2015 vision defined for the organization.
Garphi supported the Development Efficiency initiative team with high quality quantitative analysis by an associate, focused on the following areas:
  • Planned vs. Actuals, across all projects/ activities in R&D, phase and priority
  • Resource demand vs. supply for different departments
  • Headcount and FTEs compliance across different departments
  • Internal and external costs by trial, patient, phase
  • The analysis helped highlight definitive areas of improvement for the organization and subsequent roll out of corrective actions.